Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01541 IMMUNEONCO-B
RT Nominal up6.150 +0.070 (+1.151%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares		 Average Price per share Current Holdings % of Issued Shares
13/11/2024Yu Zhihua1201(L)-6,251,800(L)HKD8.720(L)13,011,440(L)3.73
13/11/20241201(L)-6,251,800(L)HKD8.720(L)13,011,440(L)3.73
24/10/20241201(L)-3,165,000(L)HKD5.900(L)20,909,600(L)5.99
23/10/2024Yu Xiaoyong1201(L)-4,061,800(L)HKD5.750(L)27,242,505(L)7.81
21/10/20241201(L)-1,675,400(L)HKD5.690(L)24,074,600(L)6.90
04/10/2024LAV Asset Management (Hong Kong) Limited1201(L)-1,432,200(L)HKD7.502(L)17,237,175(L)4.94
04/10/2024Shi Yi1201(L)-1,432,200(L)HKD7.502(L)17,237,175(L)4.94
02/10/2024LAV Asset Management (Hong Kong) Limited1201(L)-2,000,000(L)HKD6.000(L)20,721,575(L)5.94
02/10/2024Shi Yi1201(L)-2,000,000(L)HKD6.000(L)20,721,575(L)5.94
30/09/2024Yu Xiaoyong1706(L)31,304,305(L)8.97
25/09/2024LAV Asset Management (Hong Kong) Limited1201(L)-2,468,000(L)HKD5.066(L)23,834,575(L)6.83
25/09/2024Shi Yi1201(L)-2,468,000(L)HKD5.066(L)23,834,575(L)6.83
05/09/2024Tian Wenzhi1201(L)-2,655,855(L)115,884,090(L)33.20
05/09/2024Halo Biomedical LP1213(L)-2,655,855(L)15,344,145(L)4.40
05/09/2024Halo Biomedical Investment II Limited1213(L)-2,655,855(L)15,344,145(L)4.40
05/09/2024Halo Biomedical Investment I Limited1213(L)-2,655,855(L)15,344,145(L)4.40
04/09/2024Shi Yi1213(L)27,721,575(L)27,721,575(L)7.94
04/09/2024Tian Wenzhi1711(L)+50,269,972(L)118,539,945(L)33.96
04/09/2024Yu Xiaoyong1113(L)+25,750,000(L)31,304,305(L)8.97
04/09/2024LAV Asset Management (Hong Kong) Limited1213(L)27,721,575(L)27,721,575(L)7.94
04/09/2024Halo Biomedical Investment II Limited1213(L)18,000,000(L)5.16
04/09/2024Halo Biomedical LP1213(L)18,000,000(L)5.16
04/09/20241113(L)+25,750,000(L)25,750,000(L)7.38
04/09/20241213(L)-25,750,000(L)11,030,390(L)43.87
04/09/2024Yu Xiaoyong1213(L)-25,750,000(L)11,030,390(L)43.87
04/09/2024Halo Biomedical Investment I Limited1213(L)18,000,000(L)5.16
04/09/2024Tian Wenzhi1711(L)-50,269,972(L)0(L)0.00
04/09/2024Ho Yao1701(L)+4,002,918(L)16,011,675(L)4.59
04/09/20241711(L)-7,758,630(L)0(L)0.00
04/09/20241711(L)-7,419,847(L)0(L)0.00
04/09/2024LAV Corporate V GP, Ltd.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024LAV GP V, L.P.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024LAV Biosciences Fund V, L.P.1213(L)15,178,770(L)15,178,770(L)4.35
04/09/20241701(L)+10,862,055(L)10,862,055(L)7.46
04/09/20241701(L)+10,862,055(L)10,862,055(L)7.46
04/09/2024LAV ImmuneOnco Hong Kong Limited1213(L)15,178,770(L)15,178,770(L)4.35
04/09/2024LAV ImmOn Hong Kong Limited1213(L)12,542,805(L)12,542,805(L)3.59
03/09/20241701(L)-7,967,925(L)0(L)0.00
03/09/2024Chen Fei1701(L)-7,967,925(L)0(L)0.00
03/09/2024GBA Fund Investment Limited1213(L)13,854,690(L)13,854,690(L)3.97
 1   2   3  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 29/11/2024 12:27
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.